AI Transforms Pharma R&D and Manufacturing Models
London, United Kingdom | March 23, 2026 The pharmaceutical industry is undergoing a profound transformation as artificial intelligence (AI),...
Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
London, United Kingdom | March 23, 2026 The pharmaceutical industry is undergoing a profound transformation as artificial intelligence (AI),...
September 3, 2025 – Mumbai & Naples – Lupin Limited announced U.S. FDA approval for its Risperidone extended-release injectable...
PharmaResearch, a regenerative medicine company headquartered in South Korea, has entered a strategic distribution partnership with France-based Laboratoires VIVACY,...
RNAConnect today announced the commercial launch of the UltraMarathonRT® (uMRT) cDNA Synthesis and Amplification Kit, a next-generation tool designed...
SHIRLEY, N.Y., August 27, 2025 — American Regent, Inc.® has announced the commercial launch of Gvoke VialDx™ (glucagon injection),...
